Inclusion Criteria:~1. Men and women (non-childbearing potential) with a diagnosis of Alzheimer's disease
according to McKhann (2011) criteria~2. Age 50-85 years (50-80 in Czech Republic)~3. MRI or CT assessment
within six months before baseline, corroborating the clinical diagnosis of AD and excluding other potential
causes of dementia, especially cerebrovascular lesions (see exclusion criteria, number 3)~4. CSF AD specific
biomarker profile; positive, defined as CSF AÎ²42 < 550 ng l-1 or an AÎ² 40/42 ratio < 0.89~5. Mild to moderate
stage of Alzheimer's disease according to MMSE ≥ 18 and ≤ 26~6. Absence of major depressive disease according
to GDS of < 5~7. Modified Hachinski Ischemic Scale ≤ 4~8. Formal education for eight or more years~9. Previous
decline in cognition for more than six months as documented in patient medical records~10. A caregiver
available and living in the same household or interacting with the patient a sufficient time each week (in
Czech Republic: providing personal care for the patient during at least 10 hours per week ) and available if
necessary to assure administration of drug~11. Patients living at home or nursing home setting without
continuous nursing care~12. General health status acceptable for a participation in a 6-month clinical
trial~13. Ability to swallow capsules~14. Stable pharmacological treatment of any other chronic condition for
at least one month prior to screening~15. Stable treatment with one of the acetylcholinesterase inhibitors
donepezil (Aricept Â®), galantamine (RazadyneÂ®), or rivastigmine (Exelon) or the partial NMDA receptor
antagonist with memantine (NamendaÂ®) at least 3-months before baseline Visit or Combination of both treatments
mentioned above~16. No regular intake of prohibited medications as noted in Section 11.8 of the protocol~17.
Signed informed consent by the patient, examined and verified to be mentally capable by an independent
physician, prior to the initiation of any study specific procedure. Signed consent of the caregiver (see
inclusion criteria 10).~
